Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
| Status: | Recruiting |
|---|---|
| Conditions: | Prostate Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 9/23/2012 |
| Start Date: | January 2009 |
| Contact: | Ann Strasbaugh, RN |
| Email: | astrasbau@surgery.bsd.uchicago.edu |
| Phone: | 773-702-0792 |
Randomized, Multi-Institution Trial of Ciprofloxacin Versus Observation for Men With an Elevated Prostate Specific Antigen (PSA)
The purpose of this study is to assess the impact of an empiric course of antibiotics for
men with an elevated PSA.
Study Objectives:
Primary Objective: To assess the impact of ciprofloxacin on the absolute and percent change
in PSA from randomization to prostate biopsy
Secondary Objective: To assess the impact of ciprofloxacin on the overall infectious
complications following prostate biopsy
The impact of observation and ciprofloxacin on PSA levels will be assessed by absolute
changes and percent PSA change. The first PSA measurement will be at the study entry and
randomization. The second PSA measurement will be immediately prior to prostate biopsy,
which will occur 21-45 days following randomization.
Inclusion Criteria:
- Men 18 yrs. or older
- An elevated PSA (>2.5 ng/ml) and normal digital rectal exam
- Have elected to proceed with a diagnostic 12-core prostate biopsy
Exclusion Criteria:
- Previous prostate biopsy
- History of prostate cancer
- Urinary tract infections or prostatitis within one year of study entry
- antibiotic use within one month prior to PSA level
- pyuria or bacteruria on urinalysis
- allergy to fluoroquinolones
We found this trial at
1
site
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
